regeneron glp-1 gip treatment muscle loss side effects Frontiers Mitigating loss of lean muscle

This route however appears to be largely ignored and probably will continue to be ignored, since the strategy so far has been to simply create agonists which are structurally designed to be resistant to DPP-4 (In fact, most modifications to extend the half-life of GLP1R/GIPR/GR agonists so far, do so by making the drugs resistant to DPP-4 )

European Journal of Endocrinology , 139(5), 552561

Helps to eliminate dark spots, scars, and uneven skin tone throughout the body

Given that a vaccine for COVID-19 is quite possibly a long way off, it is more important than ever to explore other avenues of protecting your health

E.DeRosseP.KaneJ

Figures were prepared with BioRender.com